COMMUNIQUÉS West-GlobeNewswire

-
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
09/07/2025 -
FDA Clears Updated Magstim Rapid Transcranial Magnetic Stimulation Research System
09/07/2025 -
FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer
09/07/2025 -
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
09/07/2025 -
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
09/07/2025 -
Vireo Growth Inc. Completes Loan Refinancing and Upsize With a Bank Led Syndicate
08/07/2025 -
Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet’s AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California
09/07/2025 -
Inside information: Orion upgrades full-year outlook for 2025
09/07/2025 -
Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025
09/07/2025 -
BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit
09/07/2025 -
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke
09/07/2025 -
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
09/07/2025 -
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
09/07/2025 -
Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025
09/07/2025 -
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
09/07/2025 -
Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4
09/07/2025 -
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
09/07/2025 -
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
09/07/2025 -
Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
09/07/2025
Pages